Publications by authors named "Shukun Han"

Claim this Profile
M
Multi-modal integration of histopathology and transcriptomics reveals STAB1 macrophage-associated efferocytosis as a suppressive immune mechanism in colon adenocarcinoma.
Zhanhao Chang, Chongli Zhong, Shuo Xu, Yuyang Zhang, Xingqi Guo, Shukun Han, Bing Han

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
Yang Li, Lei Fu, Baokang Wu, Xingqi Guo, Yu Shi, Yizhou Zhang, Shukun Han

Cancer Cell Int· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
Yang Li, Chao Lv, Yang Yu, Baokang Wu, Yizhou Zhang, Shukun Han

J Adv Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Baokang Wu, Lei Fu, Xingqi Guo, Huixin Hu, Yang Li, Yizhou Zhang, Shukun Han

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer.
Chao Lv, Shukun Han, Baokang Wu, Zhiyun Liang, Yang Li, Yizhou Zhang

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.
Yang Li, Shukun Han, Baokang Wu, Chongli Zhong, Yu Shi, Yizhou Zhang

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
Shukun Han, Bing Han, Zhongmin Li, Du Sun

Cell Cycle· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis